Revenue Analysis - PEN
Comprehensive quarterly and annual revenue breakdown by product lines and geographic regions to identify growth drivers and market opportunities.
PEN Corporation
Annual
Revenue by Product Line
Latest quarterly revenue breakdown by product segments
Quarterly Product Revenue
Product Revenue Details
Detailed breakdown of revenue by product line
Neuro
0.0% of total revenue
$171.4M
Peripheral Vascular
0.0% of total revenue
$99.5M
Historical Revenue Data
Quarterly product revenue breakdown over time (Last 6 records)
| Date | Neuro | Peripheral Vascular |
|---|---|---|
| 9/30/2023 | $171.4M | $99.5M |
| 6/30/2023 | $108.8M | $152.7M |
| 3/31/2023 | $98.5M | $142.8M |
| 12/31/2022 | $91.5M | $129.7M |
| 9/30/2022 | $90.3M | $123.4M |
| 6/30/2022 | $84.8M | $123.5M |
Revenue Trend Analysis
Analysis of major growing and declining segments based on recent revenue data
Product Segments
Growing Segments
Neuro+57.5%
Declining Segments
Peripheral Vascular-34.8%
Geographic Regions
Stable Segments
UNITED STATES-0.9%
Non-US0.0%
Earnings Reports
Want to see how PEN's earnings relate to revenue? View quarterly earnings results, EPS history, and earnings surprises to understand the company's profitability.
View Earnings Reports